Navigation Links
Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
Date:3/17/2010

CARLSBAD, Calif., March 17 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Barclays' 2010 Global Healthcare Conference on Tuesday, March 23, 2010 at 3:45 p.m. ET at Loews Miami Hotel.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 22 drugs in development.  Isis' drug development progr
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  Research and Markets ( http://www.researchandmarkets.com/research/rf2c5p/an_introduction ... "An Introduction to the Medical Devices Directive (London, ... their offering. This seminar provides ... legislation. It will explain the Directives and which ... how to choose one and outline what a ...
(Date:9/2/2015)... 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ... EU Pharmacovigilance Legislation (London, UK - November 16-17, 2015)" ... 15 new EU modules concerning Pharmacovigilance are a major ... in Europe . The intention of ... their requirements, examine how they overlap and fit together ...
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2
... , , BALTIMORE , ... today that it has filed a patent infringement lawsuit against XenoTech ... the United States District Court for the Northern District of ... wholly-owned subsidiaries of Sekisui Chemical.  The complaint alleges that certain processes ...
... , FREMONT, Calif. , Feb. 2 ... Gail S. Page as Chief Executive Officer of the Company and ... Chief Science Officer of the Company.  In addition, the previously announced appointment ... is now effective. Ms. Page will continue to act as Chair of ...
Cached Medicine Technology:Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 2Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 3Vermillion Announces the Reappointment of Officers and Confirmation of Director 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 3Vermillion Announces the Reappointment of Officers and Confirmation of Director 4
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... According to an ... law by California Governor Jerry Brown that aims to do away with grand juries in ... line of duty. Passed as a direct response to grand jury decisions in Ferguson and ...
(Date:9/2/2015)... ... September 02, 2015 , ... Specifically, VOI Consulting ... recently following a decision by the Centers for Medicare & Medicaid Services (CMS) ... approximately $71,000 or roughly 40% of its headline-grabbing $178,000 price tag. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... today the launch of its enhanced, cloud-based mobile ePrescribing application. The release of ... on improving prescriber usability. A leader in health technology, RxNT was one of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... intermediate or final products. Automating sample handling makes density measurements more efficient and ... each step of the automated workflow and the advantages compared to manual sample ...
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and University ... international recognition as a premier center for treatment of and research into hereditary ... bleeding and stroke. , Cure HHT, previously known as The HHT Foundation ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4
... that yoga therapy can reduce risk factors and improve the ... improve physical, psychological and spiritual //health - or so it ... reviewed the best evidence they could find on the effects ... out of 11 - trials that were good enough to ...
... An extract of grape seed heals wounds by helping new ... free radicals in the damaged area.// Researchers at Ohio State ... on wound healing. They looked at how an extract of ... in experimental animals. ,The extract had a dynamic ...
... tool to the field of medicine. An interactive video ... treatment. The days when doctors told you what treatment ... participate in the decision-making process. But sometimes this is ... new research comes up all the time. ...
... There has always been an ongoing argument regarding the do's ... retreat suggest a new and better way through the dieting ... latest fashion being the 'low carb' approach - for many ... experts at the 'no diet' women's retreat Green Mountain in ...
... better than conventional treatment for managing asthma attacks. ... immune cells known eosinophils increase// in the airways. ... how targeting this build up of eosinophils in ... asthma attack. ,The conventional treatment consists ...
... study that people who have felt psychologically low or under ... expected.// Undergraduate students in the UK all get a vaccination ... potentially fatal brain infection. So they form an ideal population ... ,Researchers at the University of Birmingham asked a group ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: